Article may be outdated

This article is 14 days old. Some details may have changed since publication.

Oncodaily·3 min read·medium

Elabrar Ebrahim’s Clinical Trial Protocol Accepted for the AACR

L
Lusine Tadevosyan
Elabrar Ebrahim’s Clinical Trial Protocol Accepted for the AACR
AI Summary

Clinical oncology resident Elabrar Ebrahim shares her experience of having her clinical trial protocol accepted for a prestigious AACR-ASCO workshop. She highlights the importance of mentorship and the inclusion of researchers from low- and middle-income countries in global oncology discussions.

Elabrar Ebrahim , Resident clinical oncology at Alexandria University, shared on LinkedIn :

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
sciencehealtheducation

Get the full story

Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.

Create free account

Already have an account? Sign in